Other languages Haemonetics Corporation

Equities

HAE

US4050241003

Market Closed - Nyse Other stock markets 04:00:02 2024-05-14 pm EDT			5-day change	1st Jan Change
97.37 ^USD	+1.21%		+2.28%	+13.87%

May. 10	Barrington Research Raises Price Target on Haemonetics to $107 From $105, Keeps Outperform Rating	MT
May. 09	Haemonetics Seeks Acquisitions	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Haemonetics Seeks Acquisitions	May. 09
Haemonetics' Fiscal Q4 Adjusted Earnings, Revenue Rise	May. 09
Haemonetics Corporation Reports Earnings Results for the Full Year Ended March 30, 2024	May. 09
Haemonetics Corporation Reports Earnings Results for the Fourth Quarter Ended March 30, 2024	May. 09
Haemonetics Corporation Provides Revenue Guidance for the Fiscal Year 2025	May. 09
Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge	Apr. 04
Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge	Apr. 04
Haemonetics Corporation completed the acquisition of Advanced Cooling Therapy, Inc.	Mar. 31
Haemonetics to Acquire Attune Medical for $160 Million	Mar. 05
Haemonetics Q3 Adjusted Earnings, Revenue Increase; Shares Rise	Feb. 08
Haemonetics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 30, 2023	Feb. 08
Haemonetics Corporation Updates Revenue Guidance for the Fiscal Year 2024	Feb. 08
Haemonetics Completes $255 Million Acquisition of OpSens	Dec. 12
Haemonetics Corporation (NYSE : HAE) completed the acquisition of Opsens Inc. (TSX : OPS).	Dec. 11
Opsens Shareholders Approve Arrangement With Haemonetics	Dec. 01
OpSens Fiscal Q4 Loss Narrows as Sales Rise 57% Ahead of Acquisition by Haemonetics	Nov. 22
Haemonetics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 02
Haemonetics Corporation Revises Revenue Guidance for the Fiscal Year 2024	Nov. 02
Haemonetics Seeks M&A	Nov. 01
Haemonetics Insider Sold Shares Worth $207,450, According to a Recent SEC Filing	23-09-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Haemonetics Corporation

Equities

HAE

US4050241003

Other languages

Filters